Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy

American Journal of Cardiology

Volumn 85, Issue 2, 2000, Pages 266-269

  Klauss, Volker ^a   König, Andreas ^a   Spes, Christoph ^a   Meiser, Bruno ^a   Rieber, Johannes ^a   Siebert, Uwe ^b   Regar, Evelyn ^a   Pfeiffer, Matthias ^a   Reichart, Bruno ^a   Theisen, Karl ^a   Mudra, Harald ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Med Policlinic Munich Klin L   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE; TACROLIMUS;

ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HEART TRANSPLANTATION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; VASCULAR DISEASE; VOLUMETRY;

EID: 17644445599     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00631-1     Document Type: Article

References (15)

1. Pham S.M., Kormos R.L., Hattler B.G., Kawai A., Tsamandas A.C., Demetris A.J., Murali S., Fricker F.J., Chang H.C., Jain A.B., Starzl T.E., Hardesty R.L., Griffith B.P. A prospective trial of tacrolimus (FK 506) in clinical heart transplantation intermediate-term results . J Thorac Cardiovasc Surg. 111:1996;764-772.
2. Rinaldi M., Pellegrini C., Martinelli L., Goggi C., Gavazzi A., Campana C., Arbustini E., Grossi Regazzi M., Ippoliti G., Vigano M. FK506 effectiveness in reducing acute rejection after heart transplantation a prospective randomized study . J Heart Lung Transplant. 10:1997;1001-1009.
3. Meiser B.M., Überfuhr, Fuchs A., Schmidt D., Pfeiffer M., Paulus D., Schulze C., Wildhirt S., von Scheidt W., Angermann C.E., Klauss V., Martin S., Reichenspurner H., Kreuzer E., Reichart B. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant. 17:1998;782-788.
4. Shibata T., Ogawa N., Koyama I., Ksaneko N., Hokazono K., Omoto R. Does FK506 accelerate the development of coronary artery disease in the transplanted heart as well as in the native heart? Transplant Proc. 25:1993;1145-1148.
5. Arai S., Teramoto S., Senoo Y. The impact of FK 506 on graft coronary disease of rat cardiac allograft - a comparison with cyclosporine. J Heart Lung Transplant. 11:1992;757-762.
6. Meiser B.M., Billingham M.E., Morris R.E. Effects of cyclosporin, FK 506, and rapamycin on graft-vessel disease. Lancet. 338:1991;1297-1298.
7. Wu G.D., Cramer D.V., Chapman F.A., Cajulis E., Wang H.K., Starzl T.E., Makowka L. FK 506 inhibits the development of transplant arteriosclerosis. Transplant Proc. 23:1991;3272-3274.
8. Davis S.F., Yeung A.C., Meredith I.T., Charbonneau F., Ganz, Selwyn A.P., Anderson T.J. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation. 93:1996;457-462.
9. Maldonado G., Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 138:1993;923-930.
10. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet. 2:1986;307-310.
11. Johnson D.E., Alderman E.L., Schroeder J.S., Gao S.Z., Hunt S., DeCampli W.M., Stinson E.B., Billingham M.E. Transplant coronary artery disease histopathologic correlations with angiographic morphology . J Am Coll Cardiol. 17:1991;449-457.
12. St.Goar F.G., Pinto F.J., Alderman E.L., Valantine H.A., Schroeder J.S., Gao S.Z., Stinson E.B., Popp R.L. Intracoronary ultrasound in cardiac transplant recipients in vivo evidence of "angiographically silent" intimal thickening . Circulation. 85:1992;979-987.
13. Kobashigawa J.A., Katznelson S., Laks S., Johnson J.A., Yeatman L., Wang X.M., Chia D., Terasaki P.I., Sabad A., Cogert G.A., Trosian K., Hamilton M.A., Moriguchi J.D., Kawata N., Hage A., Drinkwater D.C., Stevenson L.W. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 333:1995;621-627.
14. Wenke K., Meiser B., Thiery J., Nagel D., von Scheidt W., Steinbeck G., Seidel D., Reichart B. Simvastatin reduces graft vessel disease and mortality after heart transplantation. A four-year randomized trial. Circulation. 96:1997;1398-1402.
15. Van Birgelen C., Mintz G.S., de Vrey E., Kimura T., Popma J., Airiian S., Leon M., Nobuyoshi M., Serruys P.W., de Feyter P.J. Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes observations with three dimensional intravascular ultrasound in vivo . Heart. 79:1998;137-142.